Watch NRC. Know when insiders buy.
One email the day a filing lands. Free.
NRC
NRC HEALTH
21.57
+0.30 +1.41%
USD · close Sep 23
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
18
FLAG · shorts 18
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $477.1MP/E 0.4DIV YIELD —FCF YIELD 4.54%REV TTM $140M −0.2%NET INCOME $5.9M −67.3%NET DEBT $45.4M52W 11.42 – 22.77SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $35.4M | +4.0% | — | −$3.2M | −$3.3M | — | -0.15 | $1.4M | $1.3M | $62K | Aug 4 |
| Q1 2026 · Mar 31 | $34.8M | +3.7% | — | $5.6M | $3.2M | −44.3% | 0.14 | $7.2M | $1.8M | $5.3M | Aug 4 |
| Q4 2025 · Dec 31derived | $35.2M | −4.6% | — | $4.7M | $1.8M | −72.6% | 49.57 | $7.2M | $1.1M | $6.1M | Mar 5 |
| Q3 2025 · Sep 30 | $34.6M | −3.4% | — | $7.7M | $4.1M | −27.5% | 0.18 | $13.8M | $3.6M | $10.2M | Nov 7 |
| Q2 2025 · Jun 30 | $34M | −2.8% | — | $1.6M | −$106K | −101.7% | -0.01 | −$1.1M | $3M | −$4.1M | Aug 4 |
| Q1 2025 · Mar 31 | $33.6M | −5.0% | — | $8.6M | $5.8M | −9.0% | 0.25 | $6.6M | $3M | $3.7M | Aug 4 |
| Q4 2024 · Dec 31derived | $36.9M | −2.9% | — | $9.6M | $6.6M | −25.9% | 0.28 | $6.4M | $4.4M | $1.9M | Mar 5 |
| Q3 2024 · Sep 30 | $35.8M | −5.6% | — | $8M | $5.7M | −27.8% | 0.24 | $9.4M | $1.6M | $7.8M | Nov 7 |
| Q2 2024 · Jun 30 | $35M | — | — | $8.9M | $6.2M | — | 0.26 | $6.8M | $5.3M | $1.5M | Nov 7 |
| Q1 2024 · Mar 31 | $35.3M | — | — | $8.8M | $6.4M | — | 0.27 | $12M | $4.1M | $7.9M | Nov 7 |
| Q4 2023 · Dec 31derived | $38M | — | — | $11.7M | $8.9M | — | 0.36 | $11.7M | $3.8M | $7.9M | Mar 5 |
| Q3 2023 · Sep 30 | $37.9M | — | — | $10M | $7.9M | — | 0.32 | $9.8M | $4.5M | $5.3M | Nov 8 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $137.4M | — | $22.6M | $11.6M | 8.4% | 50.00 | $26.4M | $10.7M | $15.7M | $20.2M | $11M |
| FY2024 · to Dec 31 | $143.1M | — | $35.2M | $24.8M | 17.3% | 1.04 | $34.6M | $15.4M | $19.2M | $30.9M | $11.5M |
| FY2023 · to Dec 31 | $148.6M | — | $40M | $31M | 20.8% | 1.25 | $38.1M | $15.8M | $22.3M | $19.1M | $36.4M |
| FY2022 · to Dec 31 | $151.6M | — | $46.5M | $31.8M | 21.0% | 1.27 | $36.3M | $9.8M | $26.4M | $27.6M | $21M |
| FY2021 · to Dec 31 | $148M | — | $50.3M | $37.5M | 25.3% | 1.46 | $46.3M | $5.5M | $40.8M | $4.1M | $9.2M |
| FY2020 · to Dec 31 | $133.3M | — | $42.7M | $37.3M | 28.0% | 1.45 | $40.6M | $4M | $36.7M | — | $10.5M |
Every number comes from NRC HEALTH's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.